Joe Biden wants diabetes drugs that aid weight loss and treat obesity, such as Wegovy, to fall under Medicare and Medicaid.

The Biden administration has proposed a new rule to “significantly” expand coverage of anti-obesity medications for Americans ...

Millions more senior citizens and lower-income Americans could obtain coverage for costly anti-obesity drugs under a proposal ...

The Biden administration is looking to expand access to anti-obesity GLP-1 drugs like Ozempic and Wegovy for people who have ...

U.S. President Joe Biden on Tuesday proposed expanding coverage of anti-obesity drugs, like Novo Nordisk's Wegovy, for more ...

Medicare and Medicaid recipients with obesity would have access to coverage of pricey GLP-1 receptor agonists like ...

The Biden administration, in one of its last major policy directives, proposed on Tuesday that Medicare and Medicaid cover ...

The Biden administration is proposing a rule that would require the US government to cover weight-loss drugs, potentially ...

More than seven million additional Americans could get coverage for popular drugs such as Zepbound and Wegovy under the ...

The Centers for Medicare & Medicaid Services is attempting to cover anti-obesity medications under Medicare Part D and ...

Millions of obese Americans would get access to popular weekly injectables that would help them shed pounds quickly if a $35 ...